Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy

Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose ti...

Full description

Saved in:
Bibliographic Details
Published inAIDS research and therapy Vol. 19; no. 1; pp. 14 - 10
Main Authors Mashiko, Takanobu, Tsukada, Kunihisa, Takada, Hitomi, Wu, Szu-Hsien, Kanayama, Koji, Asahi, Rintaro, Mori, Masanori, Kurisaki, Akira, Oka, Shinichi, Yoshimura, Kotaro
Format Journal Article
LanguageEnglish
Published London BioMed Central 04.03.2022
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1742-6405
1742-6405
DOI10.1186/s12981-022-00432-9

Cover

Abstract Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
AbstractList The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. Keywords: Human immunodeficiency virus, HIV-associated lipodystrophy, Lipoatrophy, Gene analysis, Adipose-derived stem cell, Macrophage
The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.BACKGROUNDThe authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.METHODSAll six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.RESULTSThe time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.CONCLUSIONSOur findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
Abstract Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.
ArticleNumber 14
Audience Academic
Author Asahi, Rintaro
Mashiko, Takanobu
Wu, Szu-Hsien
Kanayama, Koji
Oka, Shinichi
Kurisaki, Akira
Takada, Hitomi
Tsukada, Kunihisa
Mori, Masanori
Yoshimura, Kotaro
Author_xml – sequence: 1
  givenname: Takanobu
  surname: Mashiko
  fullname: Mashiko, Takanobu
  organization: Department of Plastic Surgery, Jichi Medical University, Department of Plastic Surgery, University of Tokyo
– sequence: 2
  givenname: Kunihisa
  surname: Tsukada
  fullname: Tsukada, Kunihisa
  organization: AIDS Clinical Center, National Center for Global Health and Medicine
– sequence: 3
  givenname: Hitomi
  surname: Takada
  fullname: Takada, Hitomi
  organization: Stem Cell Technologies Laboratory, Graduate School of Biological Sciences, Nara Institute of Science and Technology
– sequence: 4
  givenname: Szu-Hsien
  surname: Wu
  fullname: Wu, Szu-Hsien
  organization: Department of Plastic Surgery, University of Tokyo
– sequence: 5
  givenname: Koji
  surname: Kanayama
  fullname: Kanayama, Koji
  organization: Department of Plastic Surgery, University of Tokyo
– sequence: 6
  givenname: Rintaro
  surname: Asahi
  fullname: Asahi, Rintaro
  organization: Department of Plastic Surgery, Jichi Medical University
– sequence: 7
  givenname: Masanori
  surname: Mori
  fullname: Mori, Masanori
  organization: Department of Plastic Surgery, Jichi Medical University
– sequence: 8
  givenname: Akira
  surname: Kurisaki
  fullname: Kurisaki, Akira
  organization: Stem Cell Technologies Laboratory, Graduate School of Biological Sciences, Nara Institute of Science and Technology
– sequence: 9
  givenname: Shinichi
  surname: Oka
  fullname: Oka, Shinichi
  organization: AIDS Clinical Center, National Center for Global Health and Medicine
– sequence: 10
  givenname: Kotaro
  orcidid: 0000-0002-7152-5475
  surname: Yoshimura
  fullname: Yoshimura, Kotaro
  email: kotaro-yoshimura@umin.ac.jp
  organization: Department of Plastic Surgery, Jichi Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35246167$$D View this record in MEDLINE/PubMed
BookMark eNqNk1-L1DAUxYusuH_0C_ggBUH0oWuSppn2RVgW3R1c0Af1Ndymt9MsmWbsTV0Hv7yZ6bjMiCzSh7bp75wm5ySnyVHve0yS55ydc16qt8RFVfKMCZExJnORVY-SEz6TIlOSFUd7z8fJKdEtY7kSvHiSHOeFkIqr2Uny6wp7DNak0DepWQe_xDBsX8GtCSn1bUpjbcYAPfqRUmjsyhOmwRKNmNo-XUGw2AdK72zo0g6XftVZZ2FreT3_lgGRNxYCNqmL4mZNYYjM-mnyuAVH-Gx3P0u-fnj_5fI6u_l0Nb-8uMmMkjJkpRRqZgpWlFWRS16XrG1BxKXVDKGWqpKQt3zGuJAgGmmUaIrWtGWjcoYsas6S-eTbeLjVq8EuYVhrD1ZvB_yw0DDEDBxqnjNWgylZ0XJZxJ-ZWR6jrRWKhgmJ0SufvMZ-Bes7cO7ekDO9qUVPtehYi97WoquoejepVmO9xMbEuAZwB1M5_NLbTi_8D13GNRecRYPXO4PBfx-Rgl5aMujc1IoWKldcSpGriL6c0AXEBdm-9dHRbHB9oaqqYLwQs0id_4OKV4NLa-I-a20cPxC8ORBEJuDPsICRSH_8PD9kX-2xHYILHXk3But7OgRf7OdyH8if_RmBcgLM4IkGbLWxATY-cbrWPZy5-Ev6X0Xt6qUI9wsc9K0fh3gW6CHVb0N7F_E
CitedBy_id crossref_primary_10_1097_PRS_0000000000010872
Cites_doi 10.1038/nm.1964
10.1097/01.qai.0000182230.47819.aa
10.1194/jlr.M000869
10.1016/j.cyto.2011.10.008
10.1189/jlb.0808501
10.1016/S0140-6736(99)06102-4
10.1097/PRS.0b013e31827c6df5
10.1089/scd.2012.0442
10.1038/nature11930
10.1210/jc.2015-3058
10.1038/s41572-020-0181-1
10.1086/518443
10.1002/cphy.c160028
10.1002/cbf.1388
10.1111/j.1365-2133.2009.09272.x
10.1038/nri978
10.1097/00002030-200501030-00002
10.3851/IMP2758
10.1097/00002030-200305020-00005
10.1177/135965350400900412
10.1097/00002030-200005050-00006
10.1097/QAI.0b013e31814b94e2
10.1097/QAD.0000000000000599
10.1097/00002030-200305230-00010
10.1093/infdis/jis205
10.1016/j.cell.2011.09.045
10.1097/00126334-200305010-00004
10.1097/QAD.0b013e32834dcec9
10.1097/01.qai.0000435599.27727.6c
10.1053/meta.2002.34704
10.1097/QAI.0b013e31829bdb67
10.1016/j.cps.2014.12.008
10.1172/JCI28003
10.1016/j.yexcr.2015.07.031
10.1001/archderm.141.10.1220
10.1001/jamadermatol.2016.3827
10.1097/00002030-200212060-00010
10.1007/s00428-002-0667-0
10.1016/j.cmet.2012.01.024
10.1210/jc.2015-4125
10.1093/infdis/jiv274
10.1086/430379
10.1002/jcp.20636
10.1186/1471-2199-7-33
10.1007/s10059-011-2176-y
10.2337/diabetes.54.5.1392
10.1086/599986
10.1016/S0140-6736(02)08094-7
10.1056/NEJM199507133330202
10.1159/000148252
10.1164/ajrccm.157.4.9709126
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
KPI
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1186/s12981-022-00432-9
DatabaseName Springerlink
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Global Issues
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE



MEDLINE - Academic



Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1742-6405
EndPage 10
ExternalDocumentID oai_doaj_org_article_1300bac805f14541bc73043b6e2d024e
10.1186/s12981-022-00432-9
PMC8895510
A699501527
35246167
10_1186_s12981_022_00432_9
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: Ministry of Health, Labour and Welfare
  grantid: Science Research Grants on HIV/AIDS (H25-AIDS-G-001; H28-AIDS-G-002)
  funderid: http://dx.doi.org/10.13039/501100003478
– fundername: ;
  grantid: Science Research Grants on HIV/AIDS (H25-AIDS-G-001; H28-AIDS-G-002)
GroupedDBID ---
0R~
23M
2WC
53G
5GY
5VS
6J9
7X7
88E
8C1
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KPI
KQ8
LK8
M1P
M48
M7P
M~E
N8Y
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
CITATION
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
5PM
2VQ
4.4
ADTOC
AHSBF
C1A
EJD
H13
IPNFZ
RIG
UNPAY
ID FETCH-LOGICAL-c644t-84267c505895341b80ffa2742b0eab4694a3f170124a2d4c62d5fcf8d630e0953
IEDL.DBID M48
ISSN 1742-6405
IngestDate Wed Aug 27 01:31:34 EDT 2025
Wed Aug 20 00:07:16 EDT 2025
Tue Sep 30 17:00:36 EDT 2025
Fri Sep 05 14:32:33 EDT 2025
Tue Jun 17 21:45:41 EDT 2025
Tue Jun 10 20:08:49 EDT 2025
Fri Jun 27 04:43:54 EDT 2025
Thu May 22 21:21:37 EDT 2025
Thu Jan 02 22:53:43 EST 2025
Wed Oct 01 04:46:41 EDT 2025
Thu Apr 24 23:12:32 EDT 2025
Sat Sep 06 07:29:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HIV-associated lipodystrophy
Human immunodeficiency virus
Adipose-derived stem cell
Lipoatrophy
Gene analysis
Macrophage
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c644t-84267c505895341b80ffa2742b0eab4694a3f170124a2d4c62d5fcf8d630e0953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7152-5475
OpenAccessLink https://doi.org/10.1186/s12981-022-00432-9
PMID 35246167
PQID 2636144236
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_1300bac805f14541bc73043b6e2d024e
unpaywall_primary_10_1186_s12981_022_00432_9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8895510
proquest_miscellaneous_2636144236
gale_infotracmisc_A699501527
gale_infotracacademiconefile_A699501527
gale_incontextgauss_KPI_A699501527
gale_healthsolutions_A699501527
pubmed_primary_35246167
crossref_citationtrail_10_1186_s12981_022_00432_9
crossref_primary_10_1186_s12981_022_00432_9
springer_journals_10_1186_s12981_022_00432_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-04
PublicationDateYYYYMMDD 2022-03-04
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-04
  day: 04
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle AIDS research and therapy
PublicationTitleAbbrev AIDS Res Ther
PublicationTitleAlternate AIDS Res Ther
PublicationYear 2022
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References L Gibellini (432_CR7) 2015; 337
J Shuck (432_CR12) 2013; 131
JR Koethe (432_CR18) 2017; 7
M Sievers (432_CR17) 2009; 200
K Szade (432_CR27) 2011; 31
ML Batista Jr (432_CR21) 2012; 57
UA Walker (432_CR50) 2014; 19
F Nakagawa (432_CR2) 2012; 26
N Silver (432_CR16) 2006; 7
RK Semple (432_CR40) 2006; 116
I Bogacka (432_CR36) 2005; 54
GA McComsey (432_CR42) 2005; 19
H Yu (432_CR39) 2015; 128
J Couturier (432_CR34) 2015; 29
JR Koethe (432_CR53) 2020; 6
TL Stanley (432_CR45) 2012; 205
T Satoh (432_CR30) 2013; 495
S Leroyer (432_CR49) 2011; 52
GJ Moyle (432_CR51) 2003; 33
HM Lawler (432_CR33) 2016; 101
H Suga (432_CR15) 2009; 161
JM Gallego-Escuredo (432_CR48) 2013; 64
N Friis-Møller (432_CR6) 2003; 17
C Grunfeld (432_CR47) 2007; 46
CL Westhorpe (432_CR28) 2009; 85
M Burnouf (432_CR13) 2005; 141
NP Juffermans (432_CR20) 1998; 157
FG Bechara (432_CR11) 2008; 217
V Jan (432_CR23) 2004; 9
CB Newgard (432_CR37) 2012; 15
CM Shikuma (432_CR26) 2014; 65
T Mashiko (432_CR22) 2015; 42
DC Macallan (432_CR19) 1995; 333
H Eto (432_CR29) 2013; 22
C Hadigan (432_CR44) 2002; 51
K Yoshimura (432_CR14) 2006; 208
S Nishimura (432_CR32) 2009; 15
DL Jacobson (432_CR5) 2005; 40
JP Bastard (432_CR41) 2002; 359
R Gorjao (432_CR43) 2007; 25
K Brinkman (432_CR8) 1999; 354
V Joky (432_CR9) 2002; 16
S Gordon (432_CR24) 2003; 3
A Jaworowski (432_CR25) 2007; 196
LC Howard (432_CR46) 2016; 101
P Barreiro (432_CR52) 2000; 14
PW Mallon (432_CR4) 2003; 17
J Lloreta (432_CR31) 2002; 441
P Bacchetti (432_CR3) 2005; 40
D Ho (432_CR10) 2017; 153
AK Walker (432_CR38) 2011; 147
S Miuma (432_CR1) 2018; 15
DK Thiara (432_CR35) 2015; 212
References_xml – volume: 15
  start-page: 914
  year: 2009
  ident: 432_CR32
  publication-title: Nat Med
  doi: 10.1038/nm.1964
– volume: 40
  start-page: 121
  year: 2005
  ident: 432_CR3
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000182230.47819.aa
– volume: 128
  start-page: 2881
  year: 2015
  ident: 432_CR39
  publication-title: J Cell Sci
– volume: 52
  start-page: 207
  year: 2011
  ident: 432_CR49
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M000869
– volume: 57
  start-page: 9
  year: 2012
  ident: 432_CR21
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2011.10.008
– volume: 85
  start-page: 1027
  year: 2009
  ident: 432_CR28
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0808501
– volume: 354
  start-page: 1112
  year: 1999
  ident: 432_CR8
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)06102-4
– volume: 131
  start-page: 499
  year: 2013
  ident: 432_CR12
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e31827c6df5
– volume: 22
  start-page: 985
  year: 2013
  ident: 432_CR29
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2012.0442
– volume: 495
  start-page: 524
  year: 2013
  ident: 432_CR30
  publication-title: Nature
  doi: 10.1038/nature11930
– volume: 101
  start-page: 151
  year: 2016
  ident: 432_CR46
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2015-3058
– volume: 6
  start-page: 48
  year: 2020
  ident: 432_CR53
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-020-0181-1
– volume: 196
  start-page: 38
  year: 2007
  ident: 432_CR25
  publication-title: J Infect Dis
  doi: 10.1086/518443
– volume: 7
  start-page: 1339
  year: 2017
  ident: 432_CR18
  publication-title: Compr Physiol
  doi: 10.1002/cphy.c160028
– volume: 25
  start-page: 305
  year: 2007
  ident: 432_CR43
  publication-title: Cell Biochem Funct
  doi: 10.1002/cbf.1388
– volume: 161
  start-page: 819
  year: 2009
  ident: 432_CR15
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2009.09272.x
– volume: 3
  start-page: 23
  year: 2003
  ident: 432_CR24
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri978
– volume: 19
  start-page: 15
  year: 2005
  ident: 432_CR42
  publication-title: AIDS
  doi: 10.1097/00002030-200501030-00002
– volume: 15
  start-page: 2148
  year: 2018
  ident: 432_CR1
  publication-title: Exp Ther Med
– volume: 19
  start-page: 783
  year: 2014
  ident: 432_CR50
  publication-title: Antivir Ther
  doi: 10.3851/IMP2758
– volume: 17
  start-page: 971
  year: 2003
  ident: 432_CR4
  publication-title: AIDS
  doi: 10.1097/00002030-200305020-00005
– volume: 9
  start-page: 555
  year: 2004
  ident: 432_CR23
  publication-title: Antivir Ther
  doi: 10.1177/135965350400900412
– volume: 14
  start-page: 807
  year: 2000
  ident: 432_CR52
  publication-title: AIDS
  doi: 10.1097/00002030-200005050-00006
– volume: 46
  start-page: 283
  year: 2007
  ident: 432_CR47
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e31814b94e2
– volume: 29
  start-page: 667
  year: 2015
  ident: 432_CR34
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000599
– volume: 17
  start-page: 1179
  year: 2003
  ident: 432_CR6
  publication-title: AIDS
  doi: 10.1097/00002030-200305230-00010
– volume: 205
  start-page: S383
  year: 2012
  ident: 432_CR45
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis205
– volume: 147
  start-page: 840
  year: 2011
  ident: 432_CR38
  publication-title: Cell
  doi: 10.1016/j.cell.2011.09.045
– volume: 33
  start-page: 22
  year: 2003
  ident: 432_CR51
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00126334-200305010-00004
– volume: 26
  start-page: 335
  year: 2012
  ident: 432_CR2
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32834dcec9
– volume: 65
  start-page: 151
  year: 2014
  ident: 432_CR26
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000435599.27727.6c
– volume: 51
  start-page: 1143
  year: 2002
  ident: 432_CR44
  publication-title: Metabolism
  doi: 10.1053/meta.2002.34704
– volume: 64
  start-page: 142
  year: 2013
  ident: 432_CR48
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e31829bdb67
– volume: 42
  start-page: 181
  year: 2015
  ident: 432_CR22
  publication-title: Clin Plast Surg
  doi: 10.1016/j.cps.2014.12.008
– volume: 116
  start-page: 581
  year: 2006
  ident: 432_CR40
  publication-title: J Clin Invest
  doi: 10.1172/JCI28003
– volume: 337
  start-page: 160
  year: 2015
  ident: 432_CR7
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2015.07.031
– volume: 141
  start-page: 1220
  year: 2005
  ident: 432_CR13
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.141.10.1220
– volume: 153
  start-page: 61
  year: 2017
  ident: 432_CR10
  publication-title: JAMA Dermatol
  doi: 10.1001/jamadermatol.2016.3827
– volume: 16
  start-page: 2447
  year: 2002
  ident: 432_CR9
  publication-title: AIDS
  doi: 10.1097/00002030-200212060-00010
– volume: 441
  start-page: 599
  year: 2002
  ident: 432_CR31
  publication-title: Virchows Arch
  doi: 10.1007/s00428-002-0667-0
– volume: 15
  start-page: 606
  year: 2012
  ident: 432_CR37
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2012.01.024
– volume: 101
  start-page: 1422
  year: 2016
  ident: 432_CR33
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2015-4125
– volume: 212
  start-page: 1544
  year: 2015
  ident: 432_CR35
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiv274
– volume: 40
  start-page: 1837
  year: 2005
  ident: 432_CR5
  publication-title: Clin Infect Dis
  doi: 10.1086/430379
– volume: 208
  start-page: 64
  year: 2006
  ident: 432_CR14
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20636
– volume: 7
  start-page: 33
  year: 2006
  ident: 432_CR16
  publication-title: BMC Mol Biol
  doi: 10.1186/1471-2199-7-33
– volume: 31
  start-page: 497
  year: 2011
  ident: 432_CR27
  publication-title: Mol Cells
  doi: 10.1007/s10059-011-2176-y
– volume: 54
  start-page: 1392
  year: 2005
  ident: 432_CR36
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.5.1392
– volume: 200
  start-page: 252
  year: 2009
  ident: 432_CR17
  publication-title: J Infect Dis
  doi: 10.1086/599986
– volume: 359
  start-page: 1026
  year: 2002
  ident: 432_CR41
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08094-7
– volume: 333
  start-page: 83
  year: 1995
  ident: 432_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199507133330202
– volume: 217
  start-page: 244
  year: 2008
  ident: 432_CR11
  publication-title: Dermatology
  doi: 10.1159/000148252
– volume: 157
  start-page: 1328
  year: 1998
  ident: 432_CR20
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.157.4.9709126
SSID ssj0036215
Score 2.2673826
Snippet Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of...
The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy....
Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of...
Abstract Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of...
SourceID doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 14
SubjectTerms Adipose tissues
Adipose-derived stem cell
Anti-HIV Agents - therapeutic use
Complications and side effects
DNA, Mitochondrial - analysis
DNA, Mitochondrial - metabolism
DNA, Mitochondrial - therapeutic use
Gene analysis
Genetic aspects
Health aspects
Hemophilia
Hemophilia A - complications
Hemophilia A - drug therapy
HIV infection
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - pathology
HIV-associated lipodystrophy
HIV-Associated Lipodystrophy Syndrome - genetics
Human immunodeficiency virus
Humans
Infectious Diseases
Lipoatrophy
Lipodystrophy
Lipodystrophy - chemically induced
Lipodystrophy - complications
Lipodystrophy - genetics
Macrophage
Medicine
Medicine & Public Health
Risk factors
Subcutaneous Fat - chemistry
Subcutaneous Fat - metabolism
Subcutaneous Fat - pathology
Virology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzyEEJRXoIBBSBxo1Dxsr3MsiGoLKuJAUW-W7dh0pW2yahKhFX-eGScbbUAqHDhuPF7JM-N52J5vCHmtPbfSQ1piZwWPWepsXDDG4tJkLndmxhKDtcMnn8X8lH0842dbrb7wTVgPD9wz7gCvW4y2MuE-ZZylxoJOstwIl5XgXxxaX3Bjm2Sqt8FglVO-KZGR4qABryYhbYbEK2DQxcXEDQW0_j9t8pZT-v3B5Hhreovc6KqVXv_Qy-WWYzq6S-4MESU97Fdyj1xz1S65fjLcme-S2_3JHO0Lju6Tn4g0DbRUVyW167a-wKZa-BPhSVxDa0-bztgOwkZXdw3V5WJVN462QUZ0UdEBjLWheIpLz91FvcJzGR3-cn78LdaD0F1JlzC5XDftJdCsH5DTow9f38_joQVDbCFQamMJDnxmOfYe5ODvjEy813i7axKnDaTWTOceId0zprOSWZGV3FsvS5EnDqHsHpKdqq7cY0KTwmKRq00sRBQy05KLEsHBmHec84xFJN1IRNkBnxzbZCxVyFOkUL0UFUhRBSmqIiJvxzmrHp3jSup3KOiREpG1wwfQNzXom_qbvkXkBaqJ6stUR_ugDkVR8ASbBEfkVaBAdI0Kn-98113TqE9fjidEbwYiX8MqrR6qIYBXCMg1odybUML2t5Phlxt9VTiEb-aCdqhM5JjtZ7mIyKNef8elQ9jNRCpg9myi2RPeTEeqxXlAH5egCmDII7K_2QNqMHvNlbzfH_fJP4jqyf8Q1VNyMwtbPo8Ttkd22svOPYMQsjXPg7X4BSXrZ-o
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springerlink
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA96gh-I6PlVPTWK4INX7EeSTR_PxWNPOfHBk3sLaZp6C3vtcm2RxX_emTQtW5VDH3czKSQzmY9M5jeEvNYlN7KEsMTMMh6y2JowY4yFRZ7Y1OYzFuVYO3z8WSxO2MdTfuphcrAWZjt_H0vxrgF7JCHghZDJoceF2VVyjYPixed7czEftC7o4ZgPRTF_nTcxPA6f_08tvGWGfn8iOeZJb5EbXbXWmx96tdoyRYd3yR3vQ9KDnun3yBVb7ZLrxz5Lvktu93dxtC8xuk9-IrY00FJdFdRs2voc22jhTwQksQ2tS9p0uenAUbR111BdLNd1Y2nruEKXFfXwqw3Fe1t6Zs_rNd7EaPfJxdG3UHs224KuYHKxadoLoNk8ICeHH77OF6FvuhAacI3aUILJnhmO3QY5WLhcRmWpMZ-bR1bnEEwznZYI4p4wnRTMiKTgpSllIdLIInjdQ7JT1ZV9TGiUGSxrNZEBH0ImWnJRIBwYKy3nPGEBiQeOKOMRybExxkq5yEQK1XNRAReV46LKAvJ2nLPu8TgupX6PjB4pEUvb_QEipvzRdAm9XBsZ8TJmHJZsQOuxNBc2KcCDsQF5gWKi-sLUUSOoA5FlPMK2wAF55SgQT6PCBzvfddc06tOXownRG09U1rBKo339A-wVQnBNKPcmlHDgzWT45SCvCofwlZyTDpWIFOP7JBUBedTL77h0cLSZiAXMnk0ke7I305FqeebwxiWIAqjugOwPZ0B5Rddcuvf74zn5B1Y9-b-vPyU3E3e40zBie2SnvejsM3AP2_y50wu_AMLLWSc
  priority: 102
  providerName: Springer Nature
Title Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy
URI https://link.springer.com/article/10.1186/s12981-022-00432-9
https://www.ncbi.nlm.nih.gov/pubmed/35246167
https://www.proquest.com/docview/2636144236
https://pubmed.ncbi.nlm.nih.gov/PMC8895510
https://aidsrestherapy.biomedcentral.com/track/pdf/10.1186/s12981-022-00432-9
https://doaj.org/article/1300bac805f14541bc73043b6e2d024e
UnpaywallVersion publishedVersion
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: RBZ
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: KQ8
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: KQ8
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: DOA
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: ABDBF
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: GX1
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: M~E
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: 8C1
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: M48
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: AAJSJ
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1742-6405
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036215
  issn: 1742-6405
  databaseCode: C6C
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZ2kbgIIRi3wCgGIfHAAmliu8kDQl21qSvaNAFFfbMcx9kqdUlpGkHFn-ccJ40WmAYvjRofR7LP3ZfvEPJapVyHKaQluhdxl3WNdiPGmJvEvglM3GNejHeHj0_EcMxGEz7ZIOtyR_UEFlemdlhParyYvfv5ffURFP6DVfhQvC_AZ4WQFENaZRHm3GiTbINn8lHKj1mzqwC22lY0gCDcdwVEKutLNFd-o-WoLJ7_31b7ktv680hls696m9wss7la_VCz2SXXdXiP3K1jTtqvhOQ-2TDZDrlxXO-q75A71dodra4kPSC_EIsaaKnKEqpXy_wCy27hXwQwMQXNU1qUsS4hsDR5WVCVTOd5YejScpFOM1rDtRYU13npubnI57hyo-wnh0ffXFWLhUnoDDonq2K5AJrVQzI-PPg6GLp1kQZXQyi1dENw8T3NsTohB48Yh16aKtz_jT2jYki-mQpSBH33mfITpoWf8FSnYSICzyDY3SOyleWZeUKoF2m8Bqs9DTFH6KuQiwThw1hqOOc-c0h3zRGpawRzLKQxkzaTCYWsuCiBi9JyUUYOedv0mVf4HddS7yOjG0rE3rYv8sWZrFXZbgDGSoceT7uMw5A1WEkWxML4CUQ8xiEvUExkdZG1sSCyL6KIe1hG2CGvLAXib2R4wOdMlUUhP50etYje1ERpDqPUqr4vAXOFkF0tyt0WJRgI3Wp-uZZXiU14qs5Kh_RFgOsBfiAc8riS32boEJgz0RXQu9eS7NbctFuy6bnFJw9BFMDUO2RvrQNyrdfXzv1eoyf_waqn_5zlZ-SWb_U5cD22S7aWi9I8hwhyGXfIZm_Sg99w0O2Q7X5_9GUEz_2Dk9PP8HYgBh27NtOx5uM3MBZtKg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLagkxgIIRi3wGAGIfHAItLEdp3Hgpja7iIkNrQ3y3GcrVKXVE0qVPHnOce5aAE0wWPr40j2ufv4fCbknc64kRmkJWYUc58NrfFjxpifJqGNbDJiQYK9w8cnYnLGZuf8vGkKK9vb7m1J0llqp9ZSfCzBM0lIfSF5cjhyfnybbEnOBRuQrfF49m3WWmCwyUPeNsj8dWbPCTms_j8t8jWX9Pt1ya5meo9sr_Ol3vzQi8U1t3TwkDxo4kk6rgXgEbll8x1y57ipmO-Q-_W5HK3bjR6Tn4gzDbRU5yk1m6q4wie18CeCk9iSFhkt14lZQ9Boi3VJdTpfFqWlleMQnee0gWItKZ7h0kt7VSzxVEa7T06m333dsNymdAGT001ZrYBm84ScHXw5_TzxmwcYfANhUuVLcN8jw_HlQQ7eLpFBlmms7SaB1Qkk1kxHGQK6h0yHKTMiTHlmMpmKKLAIZPeUDPIit88JDWKDLa4mMBBPyFBLLlKEBmOZ5ZyHzCPDliPKNOjk-EjGQrksRQpVc1EBF5Xjooo98qGbs6yxOW6k_oSM7igRV9v9UawuVKOmrriXaCMDng0ZhyUbsIAsSoQNU4hmrEf2UExU3aTaWQc1FnHMA3wi2CNvHQVia-R4eedCr8tSHX6d9ojeN0RZAas0uumFgL1COK4e5W6PEpTf9IbftPKqcAhvzDnpUKGIMNcPI-GRZ7X8dkuHoJuJoYDZo55k9_amP5LPLx32uARRADPukf1WB1Rj9Mob936_05N_YNWL__v6HtmenB4fqaPpyeFLcjd0ih75Adslg2q1tq8gbKyS142V-AVX2mGI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rb9MwELdgkwYIIRivwGAGIfFhi5Ymtpt8LI-q7dg0CYb2zXIcZ6vUJVWTCFX889w5DzWAJvjY-hzJvvM9fL7fEfJOpVyHKYQlehhxlw2MdiPGmJvEvglMPGRejLXDJ6dics5mF_xio4rfvnZvU5J1TQOiNGXl0TJJ6yMeiqMCrFQIYTAEUhZTzo1uk-2QRwLCr-3RaPZ11mpj0M8D3hbL_HVmzyBZ3P4_tfOGefr96WSXP71H7lTZUq1_qMViw0SNH5IHjW9JR7UwPCK3TLZLdk6a7PkuuV_f0dG69Ogx-YmY00BLVZZQvS7za2yvhT8RqMQUNE9pUcW6AgfS5FVBVTJf5oWhpeUWnWe0gWUtKN7n0itznS_xhkbZT06m313VsN8kdAGTk3VRroBm_YScjz9_-zhxm2YMrgaXqXRDMOVDzbELIQfLF4demirM88aeUTEE2UwFKYK7-0z5CdPCT3iq0zARgWcQ1O4p2cryzDwn1Is0lrtqT4NvEfoq5CJBmDCWGs65zxwyaDkidYNUjg0zFtJGLKGQNRclcFFaLsrIIQfdnGWN03Ej9QdkdEeJGNv2j3x1KZsjaxN9sdKhx9MB47BkDdqQBbEwfgKejXHIPoqJrAtWO00hRyKKuIftgh3y1lIgzkaGD3kuVVUU8vhs2iN63xClOaxSq6YuAvYKobl6lHs9SlAEujf8ppVXiUP4es5Kh_RFgHG_HwiHPKvlt1s6OOBMDATMHvYku7c3_ZFsfmVxyEMQBVDpDjlsz4BsFGBx494fdufkH1j14v--vk92zj6N5Zfp6fFLcte35zxwPbZHtspVZV6BB1nGrxsl8QsqGmXS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+and+cytometric+analyses+of+subcutaneous+adipose+tissue+in+patients+with+hemophilia+and+HIV-associated+lipodystrophy&rft.jtitle=AIDS+research+and+therapy&rft.au=Mori%2C+Masanori&rft.au=Mashiko%2C+Takanobu&rft.au=Kurisaki%2C+Akira&rft.au=Wu%2C+Szu-Hsien&rft.date=2022-03-04&rft.pub=BioMed+Central+Ltd&rft.issn=1742-6405&rft.eissn=1742-6405&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12981-022-00432-9&rft.externalDBID=n%2Fa&rft.externalDocID=A699501527
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-6405&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-6405&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-6405&client=summon